Philippe Valadon - Concepedia

Author

Philippe Valadon

Albert Einstein College of Medicine ORCID

Also Known As

P. VALADON, P. Valadon, Philippe VALADON, Philippe Valadon

Publications

Citations

H-Index

Concepts

All Affiliations

Albert Einstein College of Medicine Centre National de la Recherche Scientifique Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques Université Paris Cité Inserm

About

Philippe Valadon is an author at Albert Einstein College of Medicine specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1K
2	Biochemistry	8	8	531
3	Natural Sciences	6	6	340
4	Engineering	1	1	14
5	Health Sciences	1	1	90

Philippe Valadon

Publications

Citations

H-Index

Page 1

	Year	Citations
Characterization of a Murine Monoclonal Antibody to<i>Cryptococcus neoformans</i>Polysaccharide That Is a Candidate for Human Therapeutic Studies Arturo Casadevall, Wendy Cleare, Marta Feldmesser, Antimicrobial Agents and Chemotherapy	1998	303
Peptide inhibition of glomerular deposition of an anti-DNA antibody Bruce D. Gaynor, Chaim Putterman, Philippe Valadon, Proceedings of the National Academy of Sciences	1997	185
Peptide Libraries Define the Fine Specificity of Anti-polysaccharide Antibodies toCryptococcus neoformans Philippe Valadon, Gabriel Nussbaum, Lisa F. Boyd, Journal of Molecular Biology Peptide Libraries DefineMedicinePeptide LibraryGlycobiologyImmunology	1996	135
Melanization of <i>Cryptococcus neoformans</i> in Murine Infection Joshua D. Nosanchuk, Philippe Valadon, Marta Feldmesser, Molecular and Cellular Biology Pathogenic MicrobiologyMicrobial PathogensFungal Cell BiologyImmunologyDermatology	1999	130
Specificity of in vitro Covalent Binding of Tienilic Acid Metabolites to Human Liver Microsomes in Relationship to the Type of Hepatotoxicity: Comparison with Two Directly Hepatotoxic Drugs Sylvaine Lecoeur, Eric Bonierbale, Dominique Challine, Chemical Research in Toxicology	1994	127
Screening phage display libraries for organ-specific vascular immunotargeting <i>in vivo</i> Philippe Valadon, Jeff D. Garnett, Jacqueline E. Testa, Proceedings of the National Academy of Sciences	2005	103
Epitope Location in the <i>Cryptococcus neoformans</i> Capsule Is a Determinant of Antibody Efficacy Gabriel Nussbaum, Wendy Cleare, Arturo Casadevall, The Journal of Experimental Medicine Mabs 12A1Immunocytochemical TechniqueMicrobial PathogensImmunodeficienciesImmunology	1997	100
Thiophene S-oxides as new reactive metabolites: formation by cytochrome P-450 dependent oxidation and reaction with nucleophiles Daniel Mansuy, Philippe Valadon, Irène Erdelmeier, Journal of the American Chemical Society Chemical AnalysisAltmetric Attention ScoreOrganic ChemistryChemistryChemical Biology	1991	92
Human‐liver cytochromes <i>P</i>‐450 expressed in yeast as tools for reactive‐metabolite formation studies Marcel Garcia, Patrick M. Dansette, Philippe Valadon, European Journal of Biochemistry Metabolomic ProfilingMolecular BiologyRedox BiologyBiosynthesisMetabolic Pathway Analysis	1993	90
Thiophene Sulfoxides as Reactive Metabolites: Formation upon Microsomal Oxidation of a 3-Aroylthiophene and Fate in the Presence of Nucleophiles<i>in Vitro</i>and<i>in Vivo</i> Philippe Valadon, Patrick M. Dansette, Jean‐Pierre Girault, Chemical Research in Toxicology Organic ChemistryChemistryHeterocycle ChemistryRedox BiologyToxicological Mechanism	1996	87

Page 1